Beam Therapeutics (BEAM) News Today $17.01 +0.21 (+1.25%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BEAM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Sumitomo Mitsui Trust Group Inc.3 hours ago | marketbeat.com10 Under-the-Radar Healthcare Stocks With Incredible Growth PotentialJune 28 at 10:05 AM | fool.comBeam Therapeutics Inc Ownership - MorningstarJune 25, 2025 | morningstar.comMBeam Therapeutics Inc. (NASDAQ:BEAM) Receives $48.75 Consensus Target Price from BrokeragesJune 21, 2025 | americanbankingnews.comBeam Therapeutics: Progress Of BEAM-101 Presses Forward With H2 2025 Data ReleasesJune 20, 2025 | seekingalpha.com‘Life just changed.’ How Miami doctors use tech to treat cancer and sickle cellJune 19, 2025 | msn.comBeam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of "Buy" by AnalystsJune 18, 2025 | marketbeat.comGAMMA Investing LLC Raises Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)June 18, 2025 | marketbeat.comEli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.June 17, 2025 | msn.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Should You Buy?June 17, 2025 | marketbeat.comRhumbline Advisers Acquires 14,971 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)June 16, 2025 | marketbeat.comBeam reports positive results from sickle cell disease treatmentJune 13, 2025 | msn.comBeam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 CongressJune 13, 2025 | globenewswire.comCathie Wood’s ARK ETFs adjust holdings, buying GitLab and Beam Therapeutics stockJune 11, 2025 | investing.comEquities Analysts Set Expectations for BEAM FY2026 EarningsJune 11, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - What's Next?June 6, 2025 | marketbeat.comBeam gets FDA orphan drug status for sickle cell disease treatmentJune 3, 2025 | msn.comBeam Therapeutics Gets FDA Orphan Drug Designation for Sickle-Cell Disease TreatmentJune 3, 2025 | marketwatch.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell DiseaseJune 3, 2025 | globenewswire.comTwo Sigma Investments LP Increases Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)June 1, 2025 | marketbeat.comBank of America Corp DE Has $3.40 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)June 1, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading Down 2.7% - Time to Sell?May 30, 2025 | marketbeat.comFDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)’ AATD Gene TherapyMay 30, 2025 | msn.comBeam Therapeutics Says FDA Grants Orphan Drug Designation to Lung, Liver TreatmentMay 29, 2025 | marketwatch.comSA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAMMay 29, 2025 | msn.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)May 29, 2025 | uk.finance.yahoo.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)May 29, 2025 | globenewswire.comBeam Therapeutics: A Cautious Hold On A Base Editing PioneerMay 29, 2025 | seekingalpha.comCandel Shares Rise After FDA Regenerative Medicine Advanced Therapy DesignationMay 29, 2025 | marketwatch.comPolar Asset Management Partners Inc. Has $5.17 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)May 28, 2025 | marketbeat.comSquarepoint Ops LLC Invests $3.85 Million in Beam Therapeutics Inc. (NASDAQ:BEAM)May 28, 2025 | marketbeat.comVoloridge Investment Management LLC Has $10.25 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)May 27, 2025 | marketbeat.comWoodline Partners LP Takes Position in Beam Therapeutics Inc. (NASDAQ:BEAM)May 26, 2025 | marketbeat.comDeutsche Bank AG Has $1.67 Million Position in Beam Therapeutics Inc. (NASDAQ:BEAM)May 26, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of "Buy" from AnalystsMay 26, 2025 | marketbeat.comGoogle Beam Futuristic AI-Powered 3D Video Chats Are Coming This YearMay 23, 2025 | msn.comTwinbeech Capital LP Purchases 69,456 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)May 23, 2025 | marketbeat.comRafferty Asset Management LLC Has $2.76 Million Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)May 22, 2025 | marketbeat.comPoint72 Asset Management L.P. Buys Shares of 193,356 Beam Therapeutics Inc. (NASDAQ:BEAM)May 22, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Sold by Tang Capital Management LLCMay 20, 2025 | marketbeat.comRaiffeisen Bank International AG Invests $1.26 Million in Beam Therapeutics Inc. (NASDAQ:BEAM)May 19, 2025 | marketbeat.comPolar Asset Management Partners Inc. Acquires 187,455 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)May 18, 2025 | marketbeat.comHudson Bay Capital Management LP Sells 15,000 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)May 16, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Northern Trust CorpMay 16, 2025 | marketbeat.comAlgert Global LLC Has $233,000 Position in Beam Therapeutics Inc. (NASDAQ:BEAM)May 15, 2025 | marketbeat.comBeam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 CongressMay 14, 2025 | globenewswire.comBeam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare ConferenceMay 13, 2025 | globenewswire.comHC Wainwright Issues Positive Forecast for BEAM EarningsMay 13, 2025 | marketbeat.comBeam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)May 12, 2025 | globenewswire.comLeerink Partnrs Issues Optimistic Forecast for BEAM EarningsMay 11, 2025 | marketbeat.com Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address BEAM Media Mentions By Week BEAM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼0.910.90▲Average Medical News Sentiment BEAM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼47▲BEAM Articles Average Week Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELAN News LEGN News TGTX News GRFS News LNTH News TLX News NUVL News AXSM News AKRO News PCVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.